Skip to main content
Top
Published in: Annals of Hematology 7/2011

01-07-2011 | Original Article

Additional erythrocytic and reticulocytic parameters helpful for diagnosis of hereditary spherocytosis: results of a multicentre study

Authors: François Mullier, Elodie Lainey, Odile Fenneteau, Lydie Da Costa, Françoise Schillinger, Nicolas Bailly, Yvan Cornet, Christian Chatelain, Jean-Michel Dogne, Bernard Chatelain

Published in: Annals of Hematology | Issue 7/2011

Login to get access

Abstract

Hereditary spherocytosis (HS) is characterised by weakened vertical linkages between the membrane skeleton and the red blood cell’s lipid bilayer, leading to the release of microparticles. All the reference tests suffer from specific limitations. The aim of this study was to develop easy to use diagnostic tool for screening of hereditary spherocytosis based on routinely acquired haematological parameters like percentage of microcytes, percentage of hypochromic cells, reticulocyte counts, and percentage of immature reticulocytes. The levels of haemoglobin, mean cell volume, mean corpuscular haemoglobin concentration, reticulocytes (Ret), immature reticulocytes fraction (IRF), hypochromic erythrocytes (Hypo-He) and microcytic erythrocytes (MicroR) were determined on EDTA samples on Sysmex instruments from a cohort of 45 confirmed SH. The HS group was then compared with haemolytical disorders, microcytic anaemia, healthy individuals and routine samples (n = 1,488). HS is characterised by a high Ret count without an equally elevated IRF. All 45 HS have Ret >80,000/μl and Ret(109/L)/IRF (%) greater than 7.7 (rule 1). Trait and mild HS had a Ret/IRF ratio greater than 19. Moderate and severe HS had increased MicroR and MicroR/Hypo-He (rule 2). Combination of both rules gave predictive positive value and negative predictive value of respectively 75% and 100% (n = 1,488), which is much greater than single parameters or existing rules. This simple and fast diagnostic method could be used as an excellent screening tool for HS. It is also valid for mild HS, neonates and ABO incompatibilities and overcomes the lack of sensitivity of electrophoresis in ankyrin deficiencies.
Literature
1.
go back to reference King MJ, Behrens J, Rogers C, Flynn C, Greenwood D, Chambers K (2000) Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 111(3):924–933PubMedCrossRef King MJ, Behrens J, Rogers C, Flynn C, Greenwood D, Chambers K (2000) Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 111(3):924–933PubMedCrossRef
2.
go back to reference Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ (2004) Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 126(4):455–474PubMedCrossRef Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ (2004) Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 126(4):455–474PubMedCrossRef
3.
4.
go back to reference Miraglia del Giudice E, Francese M, Polito R, Nobili B, Iolascon A, Perrotta S (1997) Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ank1) allele. Haematologica 82(3):332–333PubMed Miraglia del Giudice E, Francese M, Polito R, Nobili B, Iolascon A, Perrotta S (1997) Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ank1) allele. Haematologica 82(3):332–333PubMed
5.
go back to reference An X, Mohandas N (2008) Disorders of red cell membrane. Br J Haematol 141(3):367–375PubMed An X, Mohandas N (2008) Disorders of red cell membrane. Br J Haematol 141(3):367–375PubMed
6.
go back to reference Cynober T, Mohandas N, Tchernia G (1996) Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med 128(3):259–269PubMedCrossRef Cynober T, Mohandas N, Tchernia G (1996) Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med 128(3):259–269PubMedCrossRef
7.
go back to reference Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS (1997) Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr 130(6):957–960PubMedCrossRef Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS (1997) Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr 130(6):957–960PubMedCrossRef
8.
go back to reference Kutter D, Coulon N, Stirn F, Thoma M, Janecki J (2002) Demonstration and quantification of “hyperchromic” erythrocytes by haematological analysers. Application to screening for hereditary and acquired spherocytosis. Clin Lab 48(3–4):163–170PubMed Kutter D, Coulon N, Stirn F, Thoma M, Janecki J (2002) Demonstration and quantification of “hyperchromic” erythrocytes by haematological analysers. Application to screening for hereditary and acquired spherocytosis. Clin Lab 48(3–4):163–170PubMed
9.
go back to reference Da Costa L, Mohandas N, Sorette M, Grange MJ, Tchernia G, Cynober T (2001) Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia. Blood 98(10):2894–2899PubMedCrossRef Da Costa L, Mohandas N, Sorette M, Grange MJ, Tchernia G, Cynober T (2001) Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia. Blood 98(10):2894–2899PubMedCrossRef
10.
go back to reference Chiron M, Cynober T, Mielot F, Tchernia G, Croisille L (1999) The gen.S: a fortuitous finding of a routine screening test for hereditary spherocytosis. Hematol Cell Ther 41(3):113–116PubMedCrossRef Chiron M, Cynober T, Mielot F, Tchernia G, Croisille L (1999) The gen.S: a fortuitous finding of a routine screening test for hereditary spherocytosis. Hematol Cell Ther 41(3):113–116PubMedCrossRef
11.
go back to reference Girodon F, Garcon L, Bergoin E, Largier M, Delaunay J, Feneant-Thibault M, Maynadie M, Couillaud G, Moreira S, Cynober T (2008) Usefulness of the eosin-5′-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis. Br J Haematol 140(4):468–470PubMedCrossRef Girodon F, Garcon L, Bergoin E, Largier M, Delaunay J, Feneant-Thibault M, Maynadie M, Couillaud G, Moreira S, Cynober T (2008) Usefulness of the eosin-5′-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis. Br J Haematol 140(4):468–470PubMedCrossRef
12.
go back to reference King MJ, Telfer P, MacKinnon H, Langabeer L, McMahon C, Darbyshire P, Dhermy D (2008) Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. Cytometry 74(4):244–250PubMedCrossRef King MJ, Telfer P, MacKinnon H, Langabeer L, McMahon C, Darbyshire P, Dhermy D (2008) Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. Cytometry 74(4):244–250PubMedCrossRef
13.
go back to reference Urrechaga E, Borque L, Escanero JF (2009) Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. Clin Chem Lab Med 47(11):1411–1416PubMedCrossRef Urrechaga E, Borque L, Escanero JF (2009) Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. Clin Chem Lab Med 47(11):1411–1416PubMedCrossRef
14.
go back to reference Saada V, Cynober T, Brossard Y, Schischmanoff PO, Sender A, Cohen H, Delaunay J, Tchernia G (2006) Incidence of hereditary spherocytosis in a population of jaundiced neonates. Pediatr Hematol Oncol 23(5):387–397PubMedCrossRef Saada V, Cynober T, Brossard Y, Schischmanoff PO, Sender A, Cohen H, Delaunay J, Tchernia G (2006) Incidence of hereditary spherocytosis in a population of jaundiced neonates. Pediatr Hematol Oncol 23(5):387–397PubMedCrossRef
15.
go back to reference Sgro M, Campbell D, Shah V (2006) Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 175(6):587–590PubMed Sgro M, Campbell D, Shah V (2006) Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 175(6):587–590PubMed
16.
go back to reference Blanc L, Liu J, Vidal M, Chasis JA, An X, Mohandas N (2009) The water channel aquaporin-1 partitions into exosomes during reticulocyte maturation: implication for the regulation of cell volume. Blood 114(18):3928–3934PubMedCrossRef Blanc L, Liu J, Vidal M, Chasis JA, An X, Mohandas N (2009) The water channel aquaporin-1 partitions into exosomes during reticulocyte maturation: implication for the regulation of cell volume. Blood 114(18):3928–3934PubMedCrossRef
17.
go back to reference Harris N, Jou JM, Devoto G, Lotz J, Pappas J, Wranovics D, Wilkinson M, Fletcher SR, Kratz A (2005) Performance evaluation of the advia 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol 11(1):62–70PubMedCrossRef Harris N, Jou JM, Devoto G, Lotz J, Pappas J, Wranovics D, Wilkinson M, Fletcher SR, Kratz A (2005) Performance evaluation of the advia 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol 11(1):62–70PubMedCrossRef
18.
go back to reference Banfi G, Mauri C, Morelli B, Di Gaetano N, Malgeri U, Melegati G (2006) Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population. Clin Chem Lab Med 44(5):616–622PubMedCrossRef Banfi G, Mauri C, Morelli B, Di Gaetano N, Malgeri U, Melegati G (2006) Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population. Clin Chem Lab Med 44(5):616–622PubMedCrossRef
19.
go back to reference Rodrigues A, Ortega C, Santos L, Teixeira A, Dinis MJ, Vasconcelos I, Lacerda J, Fonseca E (2007) Clinical utility of Beckman–Coulter Gen’s reticulocyte analysis in the study of anemia of chronic disease (ACD). Lab Hematol 13(3):85–92PubMedCrossRef Rodrigues A, Ortega C, Santos L, Teixeira A, Dinis MJ, Vasconcelos I, Lacerda J, Fonseca E (2007) Clinical utility of Beckman–Coulter Gen’s reticulocyte analysis in the study of anemia of chronic disease (ACD). Lab Hematol 13(3):85–92PubMedCrossRef
20.
go back to reference Urrechaga E (2009) Clinical utility of the new Beckman–Coulter parameter red blood cell size factor in the study of erithropoiesis. Int J Lab Hematol 31(6):623–629PubMedCrossRef Urrechaga E (2009) Clinical utility of the new Beckman–Coulter parameter red blood cell size factor in the study of erithropoiesis. Int J Lab Hematol 31(6):623–629PubMedCrossRef
21.
go back to reference Bruce LJ, Robinson HC, Guizouarn H, Borgese F, Harrison P, King MJ, Goede JS, Coles SE, Gore DM, Lutz HU, Ficarella R, Layton DM, Iolascon A, Ellory JC, Stewart GW (2005) Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, ae1. Nat Genet 37(11):1258–1263PubMedCrossRef Bruce LJ, Robinson HC, Guizouarn H, Borgese F, Harrison P, King MJ, Goede JS, Coles SE, Gore DM, Lutz HU, Ficarella R, Layton DM, Iolascon A, Ellory JC, Stewart GW (2005) Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, ae1. Nat Genet 37(11):1258–1263PubMedCrossRef
Metadata
Title
Additional erythrocytic and reticulocytic parameters helpful for diagnosis of hereditary spherocytosis: results of a multicentre study
Authors
François Mullier
Elodie Lainey
Odile Fenneteau
Lydie Da Costa
Françoise Schillinger
Nicolas Bailly
Yvan Cornet
Christian Chatelain
Jean-Michel Dogne
Bernard Chatelain
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 7/2011
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-1138-3

Other articles of this Issue 7/2011

Annals of Hematology 7/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.